NLRP1 and Cognitive impairment: A recent study also found that susceptibility to inflammasome activation was correlated with a higher likelihood of cognitive deficits in AD patients.218 Additionally, AIM2 and NLRP1 inflammasomes in particular have been implicated in AD as Alzheimer’s patients have increased NLRP1 expression in their brains.